Rhumbline Advisers Sana Biotechnology, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 171,788 shares of SANA stock, worth $300,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares

171,788

Previous 181,903 5.56%

Holding current value

$300,629

Previous $993,000 28.1%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.76 - $6.86 $38,032 - $69,388	-10,115 Reduced 5.56%	171,788 $714,000
Q2 2024 Aug 01, 2024	BUY	$5.23 - $10.44 $131,042 - $261,584	25,056 Added 15.97%	181,903 $993,000
Q1 2024 May 09, 2024	BUY	$4.2 - $11.27 $20,424 - $54,806	4,863 Added 3.2%	156,847 $1.57 Million
Q4 2023 Feb 08, 2024	BUY	$2.8 - $4.55 $5,224 - $8,490	1,866 Added 1.24%	151,984 $620,000
Q3 2023 Nov 09, 2023	SELL	$3.77 - $6.23 $10,299 - $17,020	-2,732 Reduced 1.79%	150,118 $580,000
Q2 2023 Aug 08, 2023	BUY	$3.22 - $7.53 $33,030 - $77,242	10,258 Added 7.19%	152,850 $910,000
Q1 2023 May 11, 2023	BUY	$3.11 - $4.92 $13,248 - $20,959	4,260 Added 3.08%	142,592 $466,000
Q4 2022 Feb 14, 2023	BUY	$3.19 - $6.46 $2,456 - $4,974	770 Added 0.56%	138,332 $546,000
Q3 2022 Nov 10, 2022	BUY	$5.58 - $9.04 $42,089 - $68,188	7,543 Added 5.8%	137,562 $825,000
Q2 2022 Aug 11, 2022	BUY	$4.12 - $9.35 $162,010 - $367,670	39,323 Added 43.36%	130,019 $836,000
Q1 2022 May 12, 2022	BUY	$5.24 - $15.58 $28,914 - $85,970	5,518 Added 6.48%	90,696 $749,000
Q4 2021 Feb 10, 2022	BUY	$15.18 - $23.15 $23,210 - $35,396	1,529 Added 1.83%	85,178 $1.32 Million
Q3 2021 Nov 12, 2021	BUY	$16.29 - $25.88 $974,272 - $1.55 Million	59,808 Added 250.86%	83,649 $1.88 Million
Q2 2021 Aug 05, 2021	BUY	$16.65 - $32.14 $47,618 - $91,920	2,860 Added 13.63%	23,841 $469,000
Q1 2021 May 06, 2021	BUY	$23.04 - $43.5 $483,402 - $912,673	20,981 New	20,981 $702,000

Others Institutions Holding SANA

# of Institutions

174

Shares Held

121M

Call Options Held

1.87M

Put Options Held

1.48M

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $333M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Sana Biotechnology, Inc. Transaction History